MultiOmic Health inks MoU with Alloy Therapeutics to discover and develop renal tissue-targeting drugs

Join Pharma | Login

	Editorial


	WALK THE EXTRA MILE
	Wednesday, April 2, 2025
	Global recognition to the Indian Pharmacopoeia (IP) as a book of standard has been a major issue the Indian pharmaceutical exporters, including the merchant exporters, have been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


13:00 [IST]	MultiOmic Health inks MoU with Alloy Therapeutics to discover and develop renal tissue-targeting drugs
12:00 [IST]	CHMP recommends approval for Averoa’s Xoanacyl, an oral therapy for chronic kidney disease
11:00 [IST]	Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint
10:45 [IST]	US tariff exemption to bolster Indian pharma global presence with supply of high quality medicines
10:00 [IST]	Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D centre in Basel
09:00 [IST]	Novartis receives US FDA accelerated approval for Vanrafia, the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy

more news >>

TOP NEWS


08:00 [IST]	CDSCO asks state regulators to keep vigil against use of two antibiotics in food-producing animals
08:00 [IST]	Madhya Pradesh is free from counterfeit and substandard drugs: Dr. Shobhit Khoshta
08:00 [IST]	Medical PG and PhD educators urge NMC to reverse discriminatory policy
08:00 [IST]	Lifesciences industry sees significant shifts with digital transformation & increased M&As: Chandra Ambadipudi
08:00 [IST]	Need for accurate testing solutions are higher than ever as chikungunya outbreaks increase: Dr Sameer Bhati
08:00 [IST]	PCI reiterates its authority over pharmacy education in the country

more news >>

YESTERDAY'S NEWS


18:00 [IST]	BioMarin Pharma’s phase 3 PEGASUS trial evaluating Palynziq in adolescents with phenylketonuria meets primary efficacy endpoint
17:35 [IST]	Wish medical devices also get the exemption from US reciprocal tariff, says MTaI
17:25 [IST]	Eureka Analytical Services of GBA Group acquires Teena Biolabs
17:15 [IST]	India positioned to lead South Asia in AI adoption in healthcare, driving efficiency, access, and innovation: BCG report
17:00 [IST]	SEKISUI Diagnostics launches Metrix COVID/Flu Test for use at the point-of-care and home
16:45 [IST]	Alcon introduces the first fully personalized LASIK treatment, wavelight plus, in India with CDSCO approval

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

US tariff exemption to bolster Indian pharma global presence with supply of high quality medicines Insulin Aspart 100 Iu/ml, Pack Of 3 Ml Brivaracetam 100mg Tab Mebeverine 135mg Tab Levofloxacin 500mg 100ml Infusion

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers